Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 28Lymphoma, Non-Hodgkin 25Lymphoma, Large B-Cell, Diffuse 23Lymphoma, Mantle-Cell 20Lymphoma, Follicular 20Leukemia, Lymphocytic, Chronic, B-Cell 10Lymphoma, B-Cell, Marginal Zone 9Lymphoma, Large-Cell, Immunoblastic 8Waldenstrom Macroglobulinemia 6Burkitt Lymphoma 6Lymphoma, B-Cell 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large-Cell, Anaplastic 3Leukemia 2Orbital lymphoma 1Oncology Patients Receiving Chemotherapy 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Graft vs Host Disease 1

Interventions

ibritumomab tiuxetan 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Orbital lymphoma × ibritumomab tiuxetan × Clear all
NCT00387023 2013-11-18

Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma

M.D. Anderson Cancer Center

Phase NA Completed
12 enrolled 3 charts
Lymphoid

Orbital lymphoma, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡